Report Detail
Global Dermatophytic Onychomycosis Market Insights, Forecast to 2025
- RnM3542002 |
- 19 June, 2019 |
- Global |
- 149 Pages |
- QYResearch |
- Pharma & Healthcare
Dermatophytic onychomycosis is a fungal infection of the nail plate, nail bed, and, in some cases, the skin surrounding the nail plate. It is caused by yeast, dermatophytes, and molds; dermatophytes account for 90% of all cases. The fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, infects the skin, hair, or nails. It is often perceived by people to be an active and contagious infection. Onychomycosis may persist or worsen if not treated. The fungi that cause onychomycosis exist in common sites such as floors, soil, socks, and shoes. Therapies for onychomycosis include debridement and drugs. Debridement is time consuming and minimally effective in eradicating the fungal infection. Systemic drug treatment is most effective in treating onychomycosis.
Factors such as the rising prevalence of dermatophytic onychomycosis, heavy investments to develop therapies, and frequent product innovations will aid in the steady growth of this market during the forecast period. An important factor that will impel the prospects for growth in this market is the augmented focus on combination therapies. Recently, it has been observed that a combination of topical and systemic treatment increases the cure rate when compared to individual therapies. Since combination therapies have improved clinical efficiency and are more cost-effective than terbinafine, they are increasingly being preferred over individual terbinafine-based therapies as they have a higher cure rate.
The global dermatophytic onychomycosis market is intensely competitive owing to the presence of numerous small and large vendors that operate at a local or global scale. To survive and succeed in this market, the vendors enter into strategic alliances with smaller players to manufacture and market new drugs.
The Americas dominated this market and is envisaged to retain its dominating market position by the end of 2020 owing to the presence of a well-developed healthcare system
The global Dermatophytic Onychomycosis market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dermatophytic Onychomycosis market based on company, product type, end user and key regions.
This report studies the global market size of Dermatophytic Onychomycosis in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dermatophytic Onychomycosis in these regions.
This research report categorizes the global Dermatophytic Onychomycosis market by top players/brands, region, type and end user. This report also studies the global Dermatophytic Onychomycosis market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Anacor Pharmaceuticals
Galderma
Janssen Biotech
Novartis
Valeant Pharmaceuticals
Abeona Therapeutics
Allergan
Elorac
GlaxoSmithKline
Hexima
Hisamitsu Pharmaceutical
Mayne Pharma
MediQuest Therapeutics
Meiji Seika Pharma
Merz Pharma
Moberg Pharma
NanoBio
NovaBiotics
Nuvo Research
Pfizer
Polichem
Promius Pharma
Sanofi
Seren Pharmaceuticals
Taro Pharmaceutical
Topica Pharmaceuticals
Viamet Pharmaceuticals
Market size by Product
Oral
Topical
Market size by End User
Hospitals
Clinics and laboratories
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Dermatophytic Onychomycosis market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Dermatophytic Onychomycosis market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Dermatophytic Onychomycosis companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Dermatophytic Onychomycosis submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Dermatophytic Onychomycosis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dermatophytic Onychomycosis market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Dermatophytic Onychomycosis Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Dermatophytic Onychomycosis Market Size Growth Rate by Product
- 1.4.2 Oral
- 1.4.3 Topical
- 1.5 Market by End User
- 1.5.1 Global Dermatophytic Onychomycosis Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Clinics and laboratories
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Dermatophytic Onychomycosis Market Size
- 2.1.1 Global Dermatophytic Onychomycosis Revenue 2014-2025
- 2.1.2 Global Dermatophytic Onychomycosis Sales 2014-2025
- 2.2 Dermatophytic Onychomycosis Growth Rate by Regions
- 2.2.1 Global Dermatophytic Onychomycosis Sales by Regions
- 2.2.2 Global Dermatophytic Onychomycosis Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Dermatophytic Onychomycosis Sales by Manufacturers
- 3.1.1 Dermatophytic Onychomycosis Sales by Manufacturers
- 3.1.2 Dermatophytic Onychomycosis Sales Market Share by Manufacturers
- 3.1.3 Global Dermatophytic Onychomycosis Market Concentration Ratio (CR5 and HHI)
- 3.2 Dermatophytic Onychomycosis Revenue by Manufacturers
- 3.2.1 Dermatophytic Onychomycosis Revenue by Manufacturers (2014-2019)
- 3.2.2 Dermatophytic Onychomycosis Revenue Share by Manufacturers (2014-2019)
- 3.3 Dermatophytic Onychomycosis Price by Manufacturers
- 3.4 Dermatophytic Onychomycosis Manufacturing Base Distribution, Product Types
- 3.4.1 Dermatophytic Onychomycosis Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Dermatophytic Onychomycosis Product Type
- 3.4.3 Date of International Manufacturers Enter into Dermatophytic Onychomycosis Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Dermatophytic Onychomycosis Sales by Product
- 4.2 Global Dermatophytic Onychomycosis Revenue by Product
- 4.3 Dermatophytic Onychomycosis Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Dermatophytic Onychomycosis Breakdown Data by End User
6 North America
- 6.1 North America Dermatophytic Onychomycosis by Countries
- 6.1.1 North America Dermatophytic Onychomycosis Sales by Countries
- 6.1.2 North America Dermatophytic Onychomycosis Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Dermatophytic Onychomycosis by Product
- 6.3 North America Dermatophytic Onychomycosis by End User
7 Europe
- 7.1 Europe Dermatophytic Onychomycosis by Countries
- 7.1.1 Europe Dermatophytic Onychomycosis Sales by Countries
- 7.1.2 Europe Dermatophytic Onychomycosis Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Dermatophytic Onychomycosis by Product
- 7.3 Europe Dermatophytic Onychomycosis by End User
8 Asia Pacific
- 8.1 Asia Pacific Dermatophytic Onychomycosis by Countries
- 8.1.1 Asia Pacific Dermatophytic Onychomycosis Sales by Countries
- 8.1.2 Asia Pacific Dermatophytic Onychomycosis Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Dermatophytic Onychomycosis by Product
- 8.3 Asia Pacific Dermatophytic Onychomycosis by End User
9 Central & South America
- 9.1 Central & South America Dermatophytic Onychomycosis by Countries
- 9.1.1 Central & South America Dermatophytic Onychomycosis Sales by Countries
- 9.1.2 Central & South America Dermatophytic Onychomycosis Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Dermatophytic Onychomycosis by Product
- 9.3 Central & South America Dermatophytic Onychomycosis by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Dermatophytic Onychomycosis by Countries
- 10.1.1 Middle East and Africa Dermatophytic Onychomycosis Sales by Countries
- 10.1.2 Middle East and Africa Dermatophytic Onychomycosis Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Dermatophytic Onychomycosis by Product
- 10.3 Middle East and Africa Dermatophytic Onychomycosis by End User
11 Company Profiles
- 11.1 Anacor Pharmaceuticals
- 11.1.1 Anacor Pharmaceuticals Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Anacor Pharmaceuticals Dermatophytic Onychomycosis Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Anacor Pharmaceuticals Dermatophytic Onychomycosis Products Offered
- 11.1.5 Anacor Pharmaceuticals Recent Development
- 11.2 Galderma
- 11.2.1 Galderma Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Galderma Dermatophytic Onychomycosis Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Galderma Dermatophytic Onychomycosis Products Offered
- 11.2.5 Galderma Recent Development
- 11.3 Janssen Biotech
- 11.3.1 Janssen Biotech Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Janssen Biotech Dermatophytic Onychomycosis Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Janssen Biotech Dermatophytic Onychomycosis Products Offered
- 11.3.5 Janssen Biotech Recent Development
- 11.4 Novartis
- 11.4.1 Novartis Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Novartis Dermatophytic Onychomycosis Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Novartis Dermatophytic Onychomycosis Products Offered
- 11.4.5 Novartis Recent Development
- 11.5 Valeant Pharmaceuticals
- 11.5.1 Valeant Pharmaceuticals Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Valeant Pharmaceuticals Dermatophytic Onychomycosis Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Valeant Pharmaceuticals Dermatophytic Onychomycosis Products Offered
- 11.5.5 Valeant Pharmaceuticals Recent Development
- 11.6 Abeona Therapeutics
- 11.6.1 Abeona Therapeutics Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Abeona Therapeutics Dermatophytic Onychomycosis Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Abeona Therapeutics Dermatophytic Onychomycosis Products Offered
- 11.6.5 Abeona Therapeutics Recent Development
- 11.7 Allergan
- 11.7.1 Allergan Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Allergan Dermatophytic Onychomycosis Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Allergan Dermatophytic Onychomycosis Products Offered
- 11.7.5 Allergan Recent Development
- 11.8 Elorac
- 11.8.1 Elorac Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Elorac Dermatophytic Onychomycosis Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Elorac Dermatophytic Onychomycosis Products Offered
- 11.8.5 Elorac Recent Development
- 11.9 GlaxoSmithKline
- 11.9.1 GlaxoSmithKline Company Details
- 11.9.2 Company Business Overview
- 11.9.3 GlaxoSmithKline Dermatophytic Onychomycosis Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 GlaxoSmithKline Dermatophytic Onychomycosis Products Offered
- 11.9.5 GlaxoSmithKline Recent Development
- 11.10 Hexima
- 11.10.1 Hexima Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Hexima Dermatophytic Onychomycosis Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Hexima Dermatophytic Onychomycosis Products Offered
- 11.10.5 Hexima Recent Development
- 11.11 Hisamitsu Pharmaceutical
- 11.12 Mayne Pharma
- 11.13 MediQuest Therapeutics
- 11.14 Meiji Seika Pharma
- 11.15 Merz Pharma
- 11.16 Moberg Pharma
- 11.17 NanoBio
- 11.18 NovaBiotics
- 11.19 Nuvo Research
- 11.20 Pfizer
- 11.21 Polichem
- 11.22 Promius Pharma
- 11.23 Sanofi
- 11.24 Seren Pharmaceuticals
- 11.25 Taro Pharmaceutical
- 11.26 Topica Pharmaceuticals
- 11.27 Viamet Pharmaceuticals
12 Future Forecast
- 12.1 Dermatophytic Onychomycosis Market Forecast by Regions
- 12.1.1 Global Dermatophytic Onychomycosis Sales Forecast by Regions 2019-2025
- 12.1.2 Global Dermatophytic Onychomycosis Revenue Forecast by Regions 2019-2025
- 12.2 Dermatophytic Onychomycosis Market Forecast by Product
- 12.2.1 Global Dermatophytic Onychomycosis Sales Forecast by Product 2019-2025
- 12.2.2 Global Dermatophytic Onychomycosis Revenue Forecast by Product 2019-2025
- 12.3 Dermatophytic Onychomycosis Market Forecast by End User
- 12.4 North America Dermatophytic Onychomycosis Forecast
- 12.5 Europe Dermatophytic Onychomycosis Forecast
- 12.6 Asia Pacific Dermatophytic Onychomycosis Forecast
- 12.7 Central & South America Dermatophytic Onychomycosis Forecast
- 12.8 Middle East and Africa Dermatophytic Onychomycosis Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Dermatophytic Onychomycosis Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Dermatophytic Onychomycosis . Industry analysis & Market Report on Dermatophytic Onychomycosis is a syndicated market report, published as Global Dermatophytic Onychomycosis Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Dermatophytic Onychomycosis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
